Rudolf Jan Jokl, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1304 W Bobo Newsom Hwy, Hartsville, SC 29550 Phone: 770-874-5400 |
Dr. Naveed Iqbal, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1015 S 4th St, Hartsville, SC 29550 Phone: 843-861-4342 |
News Archive
A combined evaluation of common variants with small effects and rare predisposing mutations among young female childhood cancer survivors may further stratify this high-risk population for subsequent breast cancer risk.
An engineer has developed a new technology that could draw deadly infections such as malaria from the body using magnets.
We are pleased to announce that Hartford PHO has gone live using MedVentive's advanced clinical registries and sophisticated point of care (POC) decision support platform to help them improve the quality and coordination of patient care, promote efficiency, and support their clinical integration program.
Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara Capsules, 43 and 130 mg, respectively, of Lupin Atlantis.
› Verified 4 days ago